Gout as a risk factor for osteoporosis: A Korean population-based study
- PMID: 36397454
- PMCID: PMC9666163
- DOI: 10.1097/MD.0000000000031524
Gout as a risk factor for osteoporosis: A Korean population-based study
Abstract
Uric acid acts as both an antioxidant and a pre-oxidant that induces oxidative stress; thus, it plays a paradoxical role in inflammation. However, the effect of gout, a hallmark of hyperuricemia, on osteoporosis remains unclear. Therefore, this study aimed to investigate the association between gout and osteoporosis. This retrospective cohort study used data from the Korean National Health Insurance Service Database. In total, 628,565 participants who were diagnosed with gout and prescribed medications for gout for at least 90 days were selected. The control cohort included patients with no history of gout or use of gout medication. Age and sex 1:1 propensity score matching and Cox proportional hazards models were used to investigate risk factors for osteoporosis. In total, 305,810 patients with gout met the inclusion criteria. Compared with the control group, both men and women with gout showed an increased incidence rate ratio of osteoporosis. In the stratified analysis by age, patients with gout showed an increased incidence rate ratio for osteoporosis in all age groups, except for those over 80 years of age (P < .001). Gout showed an increased hazard ratio of 1.48 (95% CI: 1.45-1.51, P < .001). The female sex has also been identified as a risk factor for osteoporosis. Patients in their 70s had the highest HR. Gout is significantly associated with the risk of osteoporosis. In particular, the results of this study showed that the incidence of osteoporosis increased up to four times in male patients in their 20s with gout compared to without gout.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–95. - PubMed
-
- Cutis EM, Harvey NC, Cooper C. The burden of osteoporosis. Harvey NC, Cooper C, (eds). In: Osteoporosis: A Life Course Epidemiology Approach to Skeletal Health. Boca Raton, FL: CRC Press. 2018. 1–20.
-
- Cooper C, Melton LJ. Epidemiology of osteoporosis. Trends Endocrinol Metab. 1992;3:224–9. - PubMed
-
- Riggs BL, Melton LJ. Osteoporosis: Etiology, Diagnosis, and Management. New York, NY: Raven Press. 1988. 162.
-
- Compston JE, Bhambhani M, Laskey MA, Murphy S, Khaw KT. Body composition and bone mass in post-menopausal women. Clin Endocrinol (Oxf). 1992;37:426–31. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
